# GLP-1 Medicines After Kidney Transplant: What Studies Found | Buy This GLP

See what observational studies found about GLP-1 treatment after a kidney transplant and how that evidence differs from the FLOW trial.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/can-you-take-a-glp1-after-a-kidney-transplant
Updated: 2026-11-14
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# GLP-1 Medicines After Kidney Transplant: What Studies Found

A review of nine retrospective studies included 338 kidney transplant recipients, most with diabetes. The studies offer limited evidence about long-term graft outcomes.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

What each population has behind it · CKD, randomized · placebo-controlled · median 3.4 years · After a transplant: · Observational · cohort studies · The studies enrolled different populations. · Transplant care requires specialist follow-up.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   A review of nine retrospective studies included 338 kidney transplant recipients. Most had diabetes.
-   One semaglutide cohort enrolled 39 recipients and reported lower weight and HbA1c. The study was too small to rule out uncommon harms.
-   FLOW tested semaglutide in people with type 2 diabetes and chronic kidney disease. It did not establish the same effects after a transplant.

Studies have examined GLP-1 medicines after kidney transplantation, mostly in people with diabetes. A review of nine retrospective studies covered 338 recipients, including 240 who received a GLP-1 medicine [\[3\]](https://buythisglp.com/research/can-you-take-a-glp1-after-a-kidney-transplant#ref-3). The evidence does not establish how well the results apply to people using these medicines solely for weight loss.

## What transplant studies found

In one retrospective study of 39 recipients, mean HbA1c fell from 8.4% to 7.4% and mean weight from 99.5 kg to 90.7 kg at the 13- to 18-month assessment [\[2\]](https://buythisglp.com/research/can-you-take-a-glp1-after-a-kidney-transplant#ref-2). The study found no significant change in graft function markers. Without a randomized comparison, it cannot establish how much of the change came from semaglutide or rule out rare harms.

The nine-study review found no clear change in average tacrolimus levels. Gastrointestinal symptoms were the most commonly reported side effects [\[3\]](https://buythisglp.com/research/can-you-take-a-glp1-after-a-kidney-transplant#ref-3). The group average does not predict what will happen to an individual patient’s medication levels.

Talk with your transplant team

Ask your transplant team whether a GLP-1 medicine fits your care plan. They can discuss what to monitor, including graft function and any immunosuppressant levels that matter for your treatment.

## How the transplant evidence differs from FLOW

The [pooled semaglutide kidney analysis](https://buythisglp.com/research/are-glp1-drugs-safe-for-your-kidneys) includes FLOW, a randomized trial in people with type 2 diabetes and chronic kidney disease. A separate FLOW analysis examined results across categories of kidney function and urine albumin [\[1\]](https://buythisglp.com/research/can-you-take-a-glp1-after-a-kidney-transplant#ref-1). Transplant studies address a different population and have less evidence about long-term graft outcomes.

The transplant evidence remains observational. Your transplant team can explain how those findings apply to your care.

## Frequently asked

What evidence is available after a kidney transplant?

A review included nine retrospective studies covering 338 kidney transplant recipients. Most participants had diabetes. The studies cannot establish long-term safety for individual patients.

What should I discuss with my transplant team?

Ask whether these medicines fit your treatment plan and what follow-up you would need for graft function, side effects and immunosuppressant levels.

## Sources

1.  \[1\] Tuttle K, Mann J, Mayrdorfer M, Rayner B, et al. (2026). Kidney and Survival Outcomes with Semaglutide by CKD Severity in the FLOW Trial Clinical Journal of the American Society of Nephrology. [PMID 41706532](https://pubmed.ncbi.nlm.nih.gov/41706532/)
2.  \[2\] Mahzari M, Alluhayyan O, Almutairi M, Bayounis M, et al. (2024). Safety and efficacy of semaglutide in post kidney transplant patients with type 2 diabetes or Post-Transplant diabetes Journal of Clinical & Translational Endocrinology. [PMID 38623181](https://pubmed.ncbi.nlm.nih.gov/38623181/)
3.  \[3\] Krisanapan P, et al. (2024). Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis Clinical Kidney Journal. [PMID 38410684](https://pubmed.ncbi.nlm.nih.gov/38410684/)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
